Skip to main content
Erschienen in: European Radiology 12/2019

02.05.2019 | Magnetic Resonance

Point estimate and reference normality interval of MRI-derived myocardial extracellular volume in healthy subjects: a systematic review and meta-analysis

verfasst von: Francesco Sardanelli, Simone Schiaffino, Moreno Zanardo, Francesco Secchi, Paola Maria Cannaò, Federico Ambrogi, Giovanni Di Leo

Erschienen in: European Radiology | Ausgabe 12/2019

Einloggen, um Zugang zu erhalten

Abstract

Objectives

To estimate the MRI-derived myocardial extracellular volume (ECV) in healthy subjects together with reference normality interval.

Methods

The study was registered on PROSPERO and reported according to PRISMA. In October 2017, a systematic search (MEDLINE/EMBASE) was performed for articles reporting MRI-derived ECV in healthy subjects. The pooled ECV (pECV) with 95% confidence interval (CI) was calculated using the random-effect model; the normality interval was calculated as pECV ± 2 root mean square of all study standard deviations. The Newcastle-Ottawa scale was used for assessing study quality, subgroup/meta-regression analyses for technical/biological covariates, and Egger test for publication bias risk.

Results

Of 282 articles, 56 were analyzed totaling 1851 subjects with age 16–68 years, body mass index 23–28 kg/m2, and left ventricular ejection fraction 58–74%. Contrast dose varied from 0.075 to 0.200 mmol/kg. Heterogeneity was high (I2 = 92%). The pECV was 25.6% (95% CI 25.2–26.0%) with a normality interval of 19.6–31.6%. pECV was slightly increasing with age (β = 0.03%, p = 0.038) and slightly decreasing with the percentage of males (β = − 0.02%, p = 0.053). Sequence type significantly (p = 0.003) impacted on pECV: the normal interval was 19.9–31.9% for MOLLI and 20.3–33.5% for ShMOLLI. Contrast type/dose, time of acquisition, and magnetic field strength did not significantly impact pECV (p > 0.093). Quality was moderate or high in 48/56 studies (86%). No risk of publication bias (p = 0.728).

Conclusions

Myocardial pECV in healthy subjects was 25.6%, increasing by 0.03% for each year of age. The ECV normality interval was 19.9–31.9% for MOLLI and 20.3–33.5% for ShMOLLI.

Key Points

• The pooled estimate of normal MRI-derived ECV based on 1851 subjects was 25.6%, slightly increasing with age and slightly decreasing with the percentage of males.
• MRI-derived ECV was independent of contrast type/dose and field strength but dependent on the imaging sequence.
• The modeled normality reference interval of MRI-derived ECV was 19.9–31.9% for the MOLLI sequence and 20.3–33.5% for the ShMOLLI sequence.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Azevedo CF, Nigri M, Higuchi ML et al (2010) Prognostic significance of myocardial fibrosis quantification by histopathology and magnetic resonance imaging in patients with severe aortic valve disease. J Am Coll Cardiol 56:278–287PubMedCrossRef Azevedo CF, Nigri M, Higuchi ML et al (2010) Prognostic significance of myocardial fibrosis quantification by histopathology and magnetic resonance imaging in patients with severe aortic valve disease. J Am Coll Cardiol 56:278–287PubMedCrossRef
2.
Zurück zum Zitat Shirani J, Pick R, Roberts WC, Maron BJ (2000) Morphology and significance of the left ventricular collagen network in young patients with hypertrophic cardiomyopathy and sudden cardiac death. J Am Coll Cardiol 35:36–44PubMedCrossRef Shirani J, Pick R, Roberts WC, Maron BJ (2000) Morphology and significance of the left ventricular collagen network in young patients with hypertrophic cardiomyopathy and sudden cardiac death. J Am Coll Cardiol 35:36–44PubMedCrossRef
3.
Zurück zum Zitat Gulati A, Jabbour A, Ismail TF et al (2013) Association of fibrosis with mortality and sudden cardiac death in patients with nonischemic dilated cardiomyopathy. JAMA 309:896–908PubMedCrossRef Gulati A, Jabbour A, Ismail TF et al (2013) Association of fibrosis with mortality and sudden cardiac death in patients with nonischemic dilated cardiomyopathy. JAMA 309:896–908PubMedCrossRef
4.
Zurück zum Zitat Becker AE, Heijmans CD, Essed CE (1991) Chronic non-ischaemic congestive heart disease and endomyocardial biopsies. Worth the extra? Eur Heart J 12:218–223PubMedCrossRef Becker AE, Heijmans CD, Essed CE (1991) Chronic non-ischaemic congestive heart disease and endomyocardial biopsies. Worth the extra? Eur Heart J 12:218–223PubMedCrossRef
5.
Zurück zum Zitat Holzmann M, Nicko A, Kühl U et al (2008) Complication rate of right ventricular endomyocardial biopsy via the femoral approach: a retrospective and prospective study analyzing 3048 diagnostic procedures over an 11-year period. Circulation 118:1722–1728PubMedCrossRef Holzmann M, Nicko A, Kühl U et al (2008) Complication rate of right ventricular endomyocardial biopsy via the femoral approach: a retrospective and prospective study analyzing 3048 diagnostic procedures over an 11-year period. Circulation 118:1722–1728PubMedCrossRef
6.
Zurück zum Zitat Yilmaz A, Kindermann I, Kindermann M et al (2010) Comparative evaluation of left and right ventricular endomyocardial biopsy: differences in complication rate and diagnostic performance. Circulation 122:900–909PubMedCrossRef Yilmaz A, Kindermann I, Kindermann M et al (2010) Comparative evaluation of left and right ventricular endomyocardial biopsy: differences in complication rate and diagnostic performance. Circulation 122:900–909PubMedCrossRef
7.
Zurück zum Zitat Schwarz F, Mall G, Zebe H et al (1983) Quantitative morphologic findings of the myocardium in idiopathic dilated cardiomyopathy. Am J Cardiol 51:501–506PubMedCrossRef Schwarz F, Mall G, Zebe H et al (1983) Quantitative morphologic findings of the myocardium in idiopathic dilated cardiomyopathy. Am J Cardiol 51:501–506PubMedCrossRef
8.
Zurück zum Zitat Schalla S, Bekkers SC, Dennert R et al (2010) Replacement and reactive myocardial fibrosis in idiopathic dilated cardiomyopathy: comparison of magnetic resonance imaging with right ventricular biopsy. Eur J Heart Fail 12:227–231PubMedCrossRef Schalla S, Bekkers SC, Dennert R et al (2010) Replacement and reactive myocardial fibrosis in idiopathic dilated cardiomyopathy: comparison of magnetic resonance imaging with right ventricular biopsy. Eur J Heart Fail 12:227–231PubMedCrossRef
9.
Zurück zum Zitat Pennell DJ, Sechtem UP, Higgins CB et al (2004) Clinical indications for cardiovascular magnetic resonance (CMR): consensus panel report. Eur Heart J 25:1940–1965PubMedCrossRef Pennell DJ, Sechtem UP, Higgins CB et al (2004) Clinical indications for cardiovascular magnetic resonance (CMR): consensus panel report. Eur Heart J 25:1940–1965PubMedCrossRef
10.
Zurück zum Zitat van Kranenburg M, Magro M, Thiele H et al (2014) Prognostic value of microvascular obstruction and infarct size, as measured by CMR in STEMI patients. JACC Cardiovasc Imaging 7:930–939PubMedCrossRef van Kranenburg M, Magro M, Thiele H et al (2014) Prognostic value of microvascular obstruction and infarct size, as measured by CMR in STEMI patients. JACC Cardiovasc Imaging 7:930–939PubMedCrossRef
11.
Zurück zum Zitat Flett AS, Hayward MP, Ashworth MT et al (2010) Equilibrium contrast cardiovascular magnetic resonance for the measurement of diffuse myocardial fibrosis: preliminary validation in humans. Circulation 122:138–144PubMedCrossRef Flett AS, Hayward MP, Ashworth MT et al (2010) Equilibrium contrast cardiovascular magnetic resonance for the measurement of diffuse myocardial fibrosis: preliminary validation in humans. Circulation 122:138–144PubMedCrossRef
12.
Zurück zum Zitat Cannaò PM, Altabella L, Petrini M, Alì M, Secchi F, Sardanelli F (2016) Novel cardiac magnetic resonance biomarkers: native T1 and extracellular volume myocardial mapping. Eur Heart J Suppl 18:E64–E71PubMedCrossRef Cannaò PM, Altabella L, Petrini M, Alì M, Secchi F, Sardanelli F (2016) Novel cardiac magnetic resonance biomarkers: native T1 and extracellular volume myocardial mapping. Eur Heart J Suppl 18:E64–E71PubMedCrossRef
13.
Zurück zum Zitat Wong TC, Piehler KM, Kang IA et al (2014) Myocardial extracellular volume fraction quantified by cardiovascular magnetic resonance is increased in diabetes and associated with mortality and incident heart failure admission. Eur Heart J 35:657–664PubMedCrossRef Wong TC, Piehler KM, Kang IA et al (2014) Myocardial extracellular volume fraction quantified by cardiovascular magnetic resonance is increased in diabetes and associated with mortality and incident heart failure admission. Eur Heart J 35:657–664PubMedCrossRef
14.
Zurück zum Zitat Kidambi A, Motwani M, Uddin A et al (2017) Myocardial extracellular volume estimation by CMR predicts functional recovery following acute MI. JACC Cardiovasc Imaging 10:989–999PubMedPubMedCentralCrossRef Kidambi A, Motwani M, Uddin A et al (2017) Myocardial extracellular volume estimation by CMR predicts functional recovery following acute MI. JACC Cardiovasc Imaging 10:989–999PubMedPubMedCentralCrossRef
15.
Zurück zum Zitat Assomull RG, Prasad SK, Lyne J et al (2006) Cardiovascular magnetic resonance, fibrosis, and prognosis in dilated cardiomyopathy. J Am Coll Cardiol 48:1977–1985PubMedCrossRef Assomull RG, Prasad SK, Lyne J et al (2006) Cardiovascular magnetic resonance, fibrosis, and prognosis in dilated cardiomyopathy. J Am Coll Cardiol 48:1977–1985PubMedCrossRef
16.
Zurück zum Zitat O’Hanlon R, Grasso A, Roughton M et al (2010) Prognostic significance of myocardial fibrosis in hypertrophic cardiomyopathy. J Am Coll Cardiol 56:867–874PubMedCrossRef O’Hanlon R, Grasso A, Roughton M et al (2010) Prognostic significance of myocardial fibrosis in hypertrophic cardiomyopathy. J Am Coll Cardiol 56:867–874PubMedCrossRef
17.
Zurück zum Zitat Fontana M, White SK, Banypersad SM et al (2012) Comparison of T1 mapping techniques for ECV quantification. Histological validation and reproducibility of ShMOLLI versus multibreath-hold T1 quantification equilibrium contrast CMR. J Cardiovasc Magn Reson 14:88PubMedPubMedCentralCrossRef Fontana M, White SK, Banypersad SM et al (2012) Comparison of T1 mapping techniques for ECV quantification. Histological validation and reproducibility of ShMOLLI versus multibreath-hold T1 quantification equilibrium contrast CMR. J Cardiovasc Magn Reson 14:88PubMedPubMedCentralCrossRef
18.
Zurück zum Zitat Miller CA, Naish JH, Bishop P et al (2013) Comprehensive validation of cardiovascular magnetic resonance techniques for the assessment of myocardial extracellular volume. Circ Cardiovasc Imaging 6:373–383PubMedCrossRef Miller CA, Naish JH, Bishop P et al (2013) Comprehensive validation of cardiovascular magnetic resonance techniques for the assessment of myocardial extracellular volume. Circ Cardiovasc Imaging 6:373–383PubMedCrossRef
19.
Zurück zum Zitat Haaf P, Garg P, Messroghli DR, Broadbent DA, Greenwood JP, Plein S (2016) Cardiac T1 mapping and extracellular volume (ECV) in clinical practice: a comprehensive review. J Cardiovasc Magn Reson 18:89PubMedPubMedCentralCrossRef Haaf P, Garg P, Messroghli DR, Broadbent DA, Greenwood JP, Plein S (2016) Cardiac T1 mapping and extracellular volume (ECV) in clinical practice: a comprehensive review. J Cardiovasc Magn Reson 18:89PubMedPubMedCentralCrossRef
20.
Zurück zum Zitat Messroghli DR, Niendorf T, Schulz-Menger J, Dietz R, Friedrich MG (2003) T1 mapping in patients with acute myocardial infarction. J Cardiovasc Magn Reson 5:353–359PubMedCrossRef Messroghli DR, Niendorf T, Schulz-Menger J, Dietz R, Friedrich MG (2003) T1 mapping in patients with acute myocardial infarction. J Cardiovasc Magn Reson 5:353–359PubMedCrossRef
21.
Zurück zum Zitat Messroghli DR, Walters K, Plein S et al (2007) Myocardial T1 mapping: application to patients with acute and chronic myocardial infarction. Magn Reson Med 58:34–40PubMedCrossRef Messroghli DR, Walters K, Plein S et al (2007) Myocardial T1 mapping: application to patients with acute and chronic myocardial infarction. Magn Reson Med 58:34–40PubMedCrossRef
22.
Zurück zum Zitat St John Sutton MG, Lie JT, Anderson KR, O'Brien PC, Frye RL (1980) Histopathological specificity of hypertrophic obstructive cardiomyopathy. Myocardial fibre disarray and myocardial fibrosis. Br Heart J 44:433–443CrossRef St John Sutton MG, Lie JT, Anderson KR, O'Brien PC, Frye RL (1980) Histopathological specificity of hypertrophic obstructive cardiomyopathy. Myocardial fibre disarray and myocardial fibrosis. Br Heart J 44:433–443CrossRef
23.
Zurück zum Zitat Villari B, Campbell SE, Hess OM et al (1993) Influence of collagen network on left ventricular systolic and diastolic function in aortic valve disease. J Am Coll Cardiol 22:1477–1484PubMedCrossRef Villari B, Campbell SE, Hess OM et al (1993) Influence of collagen network on left ventricular systolic and diastolic function in aortic valve disease. J Am Coll Cardiol 22:1477–1484PubMedCrossRef
24.
Zurück zum Zitat Moon JC, Messroghli DR, Kellman P et al (2013) Myocardial T1 mapping and extracellular volume quantification: a Society for Cardiovascular Magnetic Resonance (SCMR) and CMR Working Group of the European Society of Cardiology consensus statement. J Cardiovasc Magn Reson 15:92PubMedPubMedCentralCrossRef Moon JC, Messroghli DR, Kellman P et al (2013) Myocardial T1 mapping and extracellular volume quantification: a Society for Cardiovascular Magnetic Resonance (SCMR) and CMR Working Group of the European Society of Cardiology consensus statement. J Cardiovasc Magn Reson 15:92PubMedPubMedCentralCrossRef
26.
Zurück zum Zitat Moher D, Liberati A, Tetzlaff J, Altman DG (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med 6:e1000097PubMedPubMedCentralCrossRef Moher D, Liberati A, Tetzlaff J, Altman DG (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med 6:e1000097PubMedPubMedCentralCrossRef
27.
Zurück zum Zitat Borenstein M, Hedges LV, Higgins JP, Rothstein HR (2010) A basic introduction to fixed-effect and random-effects models for meta-analysis. Res Synth Methods 1:97–111PubMedCrossRef Borenstein M, Hedges LV, Higgins JP, Rothstein HR (2010) A basic introduction to fixed-effect and random-effects models for meta-analysis. Res Synth Methods 1:97–111PubMedCrossRef
28.
Zurück zum Zitat Higgins JPT, Thompson SG (2002) Quantifying heterogeneity in a meta-analysis. Stat Med 21:1539–1558PubMedCrossRef Higgins JPT, Thompson SG (2002) Quantifying heterogeneity in a meta-analysis. Stat Med 21:1539–1558PubMedCrossRef
29.
Zurück zum Zitat DerSimonian R, Laird N (1986) Meta-analysis in clinical trials. Control Clin Trials 7:177–188PubMedCrossRef DerSimonian R, Laird N (1986) Meta-analysis in clinical trials. Control Clin Trials 7:177–188PubMedCrossRef
30.
Zurück zum Zitat Benjamini Y, Hochberg Y (1995) Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc Series B Stat Methodol 57:289–300 Benjamini Y, Hochberg Y (1995) Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc Series B Stat Methodol 57:289–300
31.
Zurück zum Zitat Storz C, Hetterich H, Lorbeer R et al (2018) Myocardial tissue characterization by contrast-enhanced cardiac magnetic resonance imaging in subjects with prediabetes, diabetes, and normal controls with preserved ejection fraction from the general population. Eur Heart J Cardiovasc Imaging 19:701–708PubMedCrossRef Storz C, Hetterich H, Lorbeer R et al (2018) Myocardial tissue characterization by contrast-enhanced cardiac magnetic resonance imaging in subjects with prediabetes, diabetes, and normal controls with preserved ejection fraction from the general population. Eur Heart J Cardiovasc Imaging 19:701–708PubMedCrossRef
32.
Zurück zum Zitat Sardanelli F, Di Leo G (2009) Biostatistics for radiologists. Springer, Milan, pp 41–65CrossRef Sardanelli F, Di Leo G (2009) Biostatistics for radiologists. Springer, Milan, pp 41–65CrossRef
35.
Zurück zum Zitat Stang A (2010) Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol 25:603–605CrossRefPubMed Stang A (2010) Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol 25:603–605CrossRefPubMed
36.
Zurück zum Zitat Mordi IR, Singh S, Rudd A et al (2018) Comprehensive echocardiographic and cardiac magnetic resonance evaluation differentiates among heart failure with preserved ejection fraction patients, hypertensive patients, and healthy control subjects. JACC Cardiovasc Imaging 11:577–585PubMedCrossRef Mordi IR, Singh S, Rudd A et al (2018) Comprehensive echocardiographic and cardiac magnetic resonance evaluation differentiates among heart failure with preserved ejection fraction patients, hypertensive patients, and healthy control subjects. JACC Cardiovasc Imaging 11:577–585PubMedCrossRef
37.
Zurück zum Zitat Wang S, Hu H, Lu M et al (2017) Myocardial extracellular volume fraction quantified by cardiovascular magnetic resonance is increased in hypertension and associated with left ventricular remodeling. Eur Radiol 27:4620–4630PubMedCrossRef Wang S, Hu H, Lu M et al (2017) Myocardial extracellular volume fraction quantified by cardiovascular magnetic resonance is increased in hypertension and associated with left ventricular remodeling. Eur Radiol 27:4620–4630PubMedCrossRef
38.
Zurück zum Zitat Youn JC, Hong YJ, Lee HJ et al (2017) Contrast-enhanced T1 mapping-based extracellular volume fraction independently predicts clinical outcome in patients with non-ischemic dilated cardiomyopathy: a prospective cohort study. Eur Radiol 27:3924–3933PubMedCrossRef Youn JC, Hong YJ, Lee HJ et al (2017) Contrast-enhanced T1 mapping-based extracellular volume fraction independently predicts clinical outcome in patients with non-ischemic dilated cardiomyopathy: a prospective cohort study. Eur Radiol 27:3924–3933PubMedCrossRef
39.
Zurück zum Zitat Altabella L, Borrazzo C, Carnì M et al (2017) A feasible and automatic free tool for T1 and ECV mapping. Phys Med 33:47–55PubMedCrossRef Altabella L, Borrazzo C, Carnì M et al (2017) A feasible and automatic free tool for T1 and ECV mapping. Phys Med 33:47–55PubMedCrossRef
40.
Zurück zum Zitat Boentert M, Florian A, Dräger B, Young P, Yilmaz A (2016) Pattern and prognostic value of cardiac involvement in patients with late-onset pompe disease: a comprehensive cardiovascular magnetic resonance approach. J Cardiovasc Magn Reson 18:91 Boentert M, Florian A, Dräger B, Young P, Yilmaz A (2016) Pattern and prognostic value of cardiac involvement in patients with late-onset pompe disease: a comprehensive cardiovascular magnetic resonance approach. J Cardiovasc Magn Reson 18:91
41.
Zurück zum Zitat Bulluck H, Rosmini S, Abdel-Gadir A et al (2016) Automated extracellular volume fraction mapping provides insights into the pathophysiology of left ventricular remodeling post-reperfused ST-elevation myocardial infarction. J Am Heart Assoc 5:e003555PubMedPubMedCentralCrossRef Bulluck H, Rosmini S, Abdel-Gadir A et al (2016) Automated extracellular volume fraction mapping provides insights into the pathophysiology of left ventricular remodeling post-reperfused ST-elevation myocardial infarction. J Am Heart Assoc 5:e003555PubMedPubMedCentralCrossRef
42.
Zurück zum Zitat Hanneman K, Nguyen ET, Thavendiranathan P et al (2016) Quantification of myocardial extracellular volume fraction with cardiac MR imaging in thalassemia major. Radiology 279:720–730PubMedCrossRef Hanneman K, Nguyen ET, Thavendiranathan P et al (2016) Quantification of myocardial extracellular volume fraction with cardiac MR imaging in thalassemia major. Radiology 279:720–730PubMedCrossRef
43.
Zurück zum Zitat Lee HJ, Im DJ, Youn JC et al (2016) Myocardial extracellular volume fraction with dual-energy equilibrium contrast-enhanced cardiac CT in nonischemic cardiomyopathy: a prospective comparison with cardiac MR imaging. Radiology 280:49–57PubMedCrossRef Lee HJ, Im DJ, Youn JC et al (2016) Myocardial extracellular volume fraction with dual-energy equilibrium contrast-enhanced cardiac CT in nonischemic cardiomyopathy: a prospective comparison with cardiac MR imaging. Radiology 280:49–57PubMedCrossRef
44.
Zurück zum Zitat Luetkens JA, Homsi R, Sprinkart AM et al (2016) Incremental value of quantitative CMR including parametric mapping for the diagnosis of acute myocarditis. Eur Heart J Cardiovasc Imaging 17:154–161PubMedCrossRef Luetkens JA, Homsi R, Sprinkart AM et al (2016) Incremental value of quantitative CMR including parametric mapping for the diagnosis of acute myocarditis. Eur Heart J Cardiovasc Imaging 17:154–161PubMedCrossRef
45.
Zurück zum Zitat Luetkens JA, Doerner J, Schwarze-Zander C et al (2016) Cardiac magnetic resonance reveals signs of subclinical myocardial inflammation in asymptomatic HIV-infected patients. Circ Cardiovasc Imaging 9:e004091PubMedCrossRef Luetkens JA, Doerner J, Schwarze-Zander C et al (2016) Cardiac magnetic resonance reveals signs of subclinical myocardial inflammation in asymptomatic HIV-infected patients. Circ Cardiovasc Imaging 9:e004091PubMedCrossRef
46.
Zurück zum Zitat Mayr A, Kitterer D, Latus J et al (2016) Evaluation of myocardial involvement in patients with connective tissue disorders: a multi-parametric cardiovascular magnetic resonance study. J Cardiovasc Magn Reson 18:67PubMedPubMedCentralCrossRef Mayr A, Kitterer D, Latus J et al (2016) Evaluation of myocardial involvement in patients with connective tissue disorders: a multi-parametric cardiovascular magnetic resonance study. J Cardiovasc Magn Reson 18:67PubMedPubMedCentralCrossRef
47.
Zurück zum Zitat Mordi I, Carrick D, Bezerra H, Tzemos N (2016) T1 and T2 mapping for early diagnosis of dilated non-ischaemic cardiomyopathy in middle-aged patients and differentiation from normal physiological adaptation. Eur Heart J Cardiovasc Imaging 17:797–803PubMedCrossRef Mordi I, Carrick D, Bezerra H, Tzemos N (2016) T1 and T2 mapping for early diagnosis of dilated non-ischaemic cardiomyopathy in middle-aged patients and differentiation from normal physiological adaptation. Eur Heart J Cardiovasc Imaging 17:797–803PubMedCrossRef
48.
Zurück zum Zitat Olivieri LJ, Kellman P, McCarter RJ, Cross RR, Hansen MS, Spurney CF (2016) Native T1 values identify myocardial changes and stratify disease severity in patients with Duchenne muscular dystrophy. J Cardiovasc Magn Reson 18:72 Olivieri LJ, Kellman P, McCarter RJ, Cross RR, Hansen MS, Spurney CF (2016) Native T1 values identify myocardial changes and stratify disease severity in patients with Duchenne muscular dystrophy. J Cardiovasc Magn Reson 18:72
49.
Zurück zum Zitat Schmacht L, Traber J, Grieben U et al (2016) Cardiac involvement in myotonic dystrophy type 2 patients with preserved ejection fraction: detection by cardiovascular magnetic resonance. Circ Cardiovasc Imaging 9:e004615PubMedCrossRef Schmacht L, Traber J, Grieben U et al (2016) Cardiac involvement in myotonic dystrophy type 2 patients with preserved ejection fraction: detection by cardiovascular magnetic resonance. Circ Cardiovasc Imaging 9:e004615PubMedCrossRef
50.
Zurück zum Zitat Soslow JH, Damon SM, Crum K et al (2016) Increased myocardial native T1 and extracellular volume in patients with Duchenne muscular dystrophy. J Cardiovasc Magn Reson 18:5PubMedPubMedCentralCrossRef Soslow JH, Damon SM, Crum K et al (2016) Increased myocardial native T1 and extracellular volume in patients with Duchenne muscular dystrophy. J Cardiovasc Magn Reson 18:5PubMedPubMedCentralCrossRef
51.
Zurück zum Zitat Weingärtner S, Meßner NM, Budjan J et al (2016) Myocardial T1-mapping at 3T using saturation-recovery: reference values, precision and comparison with MOLLI. J Cardiovasc Magn Reson 18:84PubMedPubMedCentralCrossRef Weingärtner S, Meßner NM, Budjan J et al (2016) Myocardial T1-mapping at 3T using saturation-recovery: reference values, precision and comparison with MOLLI. J Cardiovasc Magn Reson 18:84PubMedPubMedCentralCrossRef
52.
Zurück zum Zitat Zhao L, Li S, Ma X et al (2016) Systolic MOLLI T1 mapping with heart-rate-dependent pulse sequence sampling scheme is feasible in patients with atrial fibrillation. J Cardiovasc Magn Reson 18:13PubMedPubMedCentralCrossRef Zhao L, Li S, Ma X et al (2016) Systolic MOLLI T1 mapping with heart-rate-dependent pulse sequence sampling scheme is feasible in patients with atrial fibrillation. J Cardiovasc Magn Reson 18:13PubMedPubMedCentralCrossRef
53.
Zurück zum Zitat aus dem Siepen F, Buss SJ, Messroghli D et al (2015) T1 mapping in dilated cardiomyopathy with cardiac magnetic resonance: quantification of diffuse myocardial fibrosis and comparison with endomyocardial biopsy. Eur Heart J Cardiovasc Imaging 16:210–216PubMedCrossRef aus dem Siepen F, Buss SJ, Messroghli D et al (2015) T1 mapping in dilated cardiomyopathy with cardiac magnetic resonance: quantification of diffuse myocardial fibrosis and comparison with endomyocardial biopsy. Eur Heart J Cardiovasc Imaging 16:210–216PubMedCrossRef
54.
Zurück zum Zitat Banypersad SM, Fontana M, Maestrini V et al (2015) T1 mapping and survival in systemic light-chain amyloidosis. Eur Heart J 36:244–251PubMedCrossRef Banypersad SM, Fontana M, Maestrini V et al (2015) T1 mapping and survival in systemic light-chain amyloidosis. Eur Heart J 36:244–251PubMedCrossRef
55.
Zurück zum Zitat Barison A, Gargani L, De Marchi D et al (2015) Early myocardial and skeletal muscle interstitial remodelling in systemic sclerosis: insights from extracellular volume quantification using cardiovascular magnetic resonance. Eur Heart J Cardiovasc Imaging 16:74–80PubMedCrossRef Barison A, Gargani L, De Marchi D et al (2015) Early myocardial and skeletal muscle interstitial remodelling in systemic sclerosis: insights from extracellular volume quantification using cardiovascular magnetic resonance. Eur Heart J Cardiovasc Imaging 16:74–80PubMedCrossRef
56.
Zurück zum Zitat Barison A, Del Torto A, Chiappino S et al (2015) Prognostic significance of myocardial extracellular volume fraction in nonischaemic dilated cardiomyopathy. J Cardiovasc Med (Hagerstown) 16:681–687CrossRef Barison A, Del Torto A, Chiappino S et al (2015) Prognostic significance of myocardial extracellular volume fraction in nonischaemic dilated cardiomyopathy. J Cardiovasc Med (Hagerstown) 16:681–687CrossRef
57.
Zurück zum Zitat Barison A, Aquaro GD, Pugliese NR et al (2015) Measurement of myocardial amyloid deposition in systemic amyloidosis: insights from cardiovascular magnetic resonance imaging. J Intern Med 277:605–614PubMedCrossRef Barison A, Aquaro GD, Pugliese NR et al (2015) Measurement of myocardial amyloid deposition in systemic amyloidosis: insights from cardiovascular magnetic resonance imaging. J Intern Med 277:605–614PubMedCrossRef
58.
Zurück zum Zitat Edwards NC, Moody WE, Yuan M et al (2015) Diffuse interstitial fibrosis and myocardial dysfunction in early chronic kidney disease. Am J Cardiol 115:1311–1317PubMedCrossRef Edwards NC, Moody WE, Yuan M et al (2015) Diffuse interstitial fibrosis and myocardial dysfunction in early chronic kidney disease. Am J Cardiol 115:1311–1317PubMedCrossRef
59.
Zurück zum Zitat Edwards NC, Moody WE, Yuan M et al (2015) Diffuse left ventricular interstitial fibrosis is associated with sub-clinical myocardial dysfunction in Alström syndrome: an observational study. Orphanet J Rare Dis 10:83PubMedPubMedCentralCrossRef Edwards NC, Moody WE, Yuan M et al (2015) Diffuse left ventricular interstitial fibrosis is associated with sub-clinical myocardial dysfunction in Alström syndrome: an observational study. Orphanet J Rare Dis 10:83PubMedPubMedCentralCrossRef
60.
Zurück zum Zitat Ertel A, Pratt D, Kellman P et al (2015) Increased myocardial extracellular volume in active idiopathic systemic capillary leak syndrome. J Cardiovasc Magn Reson 17:76PubMedPubMedCentralCrossRef Ertel A, Pratt D, Kellman P et al (2015) Increased myocardial extracellular volume in active idiopathic systemic capillary leak syndrome. J Cardiovasc Magn Reson 17:76PubMedPubMedCentralCrossRef
61.
Zurück zum Zitat Hong YJ, Park CH, Kim YJ et al (2015) Extracellular volume fraction in dilated cardiomyopathy patients without obvious late gadolinium enhancement: comparison with healthy control subjects. Int J Cardiovasc Imaging 31(Suppl 1):115–122PubMedCrossRef Hong YJ, Park CH, Kim YJ et al (2015) Extracellular volume fraction in dilated cardiomyopathy patients without obvious late gadolinium enhancement: comparison with healthy control subjects. Int J Cardiovasc Imaging 31(Suppl 1):115–122PubMedCrossRef
62.
Zurück zum Zitat Kuruvilla S, Janardhanan R, Antkowiak P et al (2015) Increased extracellular volume and altered mechanics are associated with LVH in hypertensive heart disease, not hypertension alone. JACC Cardiovasc Imaging 8:172–180PubMedPubMedCentralCrossRef Kuruvilla S, Janardhanan R, Antkowiak P et al (2015) Increased extracellular volume and altered mechanics are associated with LVH in hypertensive heart disease, not hypertension alone. JACC Cardiovasc Imaging 8:172–180PubMedPubMedCentralCrossRef
63.
Zurück zum Zitat Mehta BB, Auger DA, Gonzalez JA et al (2015) Detection of elevated right ventricular extracellular volume in pulmonary hypertension using accelerated and navigator-gated Look-Locker imaging for cardiac T1 estimation (ANGIE) cardiovascular magnetic resonance. J Cardiovasc Magn Reson 17:110PubMedPubMedCentralCrossRef Mehta BB, Auger DA, Gonzalez JA et al (2015) Detection of elevated right ventricular extracellular volume in pulmonary hypertension using accelerated and navigator-gated Look-Locker imaging for cardiac T1 estimation (ANGIE) cardiovascular magnetic resonance. J Cardiovasc Magn Reson 17:110PubMedPubMedCentralCrossRef
64.
Zurück zum Zitat Ntusi NAB, Piechnik SK, Francis JM et al (2015) Diffuse myocardial fibrosis and inflammation in rheumatoid arthritis. JACC Cardiovasc Imaging 8:526–536PubMedCrossRef Ntusi NAB, Piechnik SK, Francis JM et al (2015) Diffuse myocardial fibrosis and inflammation in rheumatoid arthritis. JACC Cardiovasc Imaging 8:526–536PubMedCrossRef
65.
Zurück zum Zitat Singh A, Horsfield MA, Bekele S, Khan JN, Greiser A, McCann GP (2015) Myocardial T1 and extracellular volume fraction measurement in asymptomatic patients with aortic stenosis: reproducibility and comparison with age-matched controls. Eur Heart J Cardiovasc Imaging 16:763–770PubMedCrossRef Singh A, Horsfield MA, Bekele S, Khan JN, Greiser A, McCann GP (2015) Myocardial T1 and extracellular volume fraction measurement in asymptomatic patients with aortic stenosis: reproducibility and comparison with age-matched controls. Eur Heart J Cardiovasc Imaging 16:763–770PubMedCrossRef
66.
Zurück zum Zitat Brouwer WP, Baars EN, Germans T et al (2014) In-vivo T1 cardiovascular magnetic resonance study of diffuse myocardial fibrosis in hypertrophic cardiomyopathy. J Cardiovasc Magn Reson 16:28PubMedPubMedCentralCrossRef Brouwer WP, Baars EN, Germans T et al (2014) In-vivo T1 cardiovascular magnetic resonance study of diffuse myocardial fibrosis in hypertrophic cardiomyopathy. J Cardiovasc Magn Reson 16:28PubMedPubMedCentralCrossRef
67.
Zurück zum Zitat Chin CW, Semple S, Malley T et al (2014) Optimization and comparison of myocardial T1 techniques at 3T in patients with aortic stenosis. Eur Heart J Cardiovasc Imaging 15:556–565PubMedPubMedCentralCrossRef Chin CW, Semple S, Malley T et al (2014) Optimization and comparison of myocardial T1 techniques at 3T in patients with aortic stenosis. Eur Heart J Cardiovasc Imaging 15:556–565PubMedPubMedCentralCrossRef
68.
Zurück zum Zitat Dabir D, Child N, Kalra A et al (2014) Reference values for healthy human myocardium using a T1 mapping methodology: results from the international T1 multicenter cardiovascular magnetic resonance study. J Cardiovasc Magn Reson 16:69PubMedPubMedCentralCrossRef Dabir D, Child N, Kalra A et al (2014) Reference values for healthy human myocardium using a T1 mapping methodology: results from the international T1 multicenter cardiovascular magnetic resonance study. J Cardiovasc Magn Reson 16:69PubMedPubMedCentralCrossRef
69.
Zurück zum Zitat Edwards NC, Moody WE, Yuan M et al (2014) Quantification of left ventricular interstitial fibrosis in asymptomatic chronic primary degenerative mitral regurgitation. Circ Cardiovasc Imaging 7:946–953PubMedCrossRef Edwards NC, Moody WE, Yuan M et al (2014) Quantification of left ventricular interstitial fibrosis in asymptomatic chronic primary degenerative mitral regurgitation. Circ Cardiovasc Imaging 7:946–953PubMedCrossRef
70.
Zurück zum Zitat Florian A, Ludwig A, Rösch S, Yildiz H, Sechtem U, Yilmaz A (2014) Myocardial fibrosis imaging based on T1-mapping and extracellular volume fraction (ECV) measurement in muscular dystrophy patients: diagnostic value compared with conventional late gadolinium enhancement (LGE) imaging. Eur Heart J Cardiovasc Imaging 15:1004–1012PubMedCrossRef Florian A, Ludwig A, Rösch S, Yildiz H, Sechtem U, Yilmaz A (2014) Myocardial fibrosis imaging based on T1-mapping and extracellular volume fraction (ECV) measurement in muscular dystrophy patients: diagnostic value compared with conventional late gadolinium enhancement (LGE) imaging. Eur Heart J Cardiovasc Imaging 15:1004–1012PubMedCrossRef
71.
Zurück zum Zitat Luetkens JA, Doerner J, Thomas DK et al (2014) Acute myocarditis: multiparametric cardiac MR imaging. Radiology 273:383–392PubMedCrossRef Luetkens JA, Doerner J, Thomas DK et al (2014) Acute myocarditis: multiparametric cardiac MR imaging. Radiology 273:383–392PubMedCrossRef
72.
Zurück zum Zitat Neilan TG, Bakker JP, Sharma B et al (2014) T1 measurements for detection of expansion of the myocardial extracellular volume in chronic obstructive pulmonary disease. Can J Cardiol 30:1668–1675PubMedCrossRef Neilan TG, Bakker JP, Sharma B et al (2014) T1 measurements for detection of expansion of the myocardial extracellular volume in chronic obstructive pulmonary disease. Can J Cardiol 30:1668–1675PubMedCrossRef
73.
Zurück zum Zitat Radunski UK, Lund GK, Stehning C et al (2014) CMR in patients with severe myocarditis: diagnostic value of quantitative tissue markers including extracellular volume imaging. JACC Cardiovasc Imaging 7:667–675PubMedCrossRef Radunski UK, Lund GK, Stehning C et al (2014) CMR in patients with severe myocarditis: diagnostic value of quantitative tissue markers including extracellular volume imaging. JACC Cardiovasc Imaging 7:667–675PubMedCrossRef
74.
Zurück zum Zitat Thuny F, Lovric D, Schnell F et al (2014) Quantification of myocardial extracellular volume fraction with cardiac MR imaging for early detection of left ventricle involvement in systemic sclerosis. Radiology 271:373–380PubMedCrossRef Thuny F, Lovric D, Schnell F et al (2014) Quantification of myocardial extracellular volume fraction with cardiac MR imaging for early detection of left ventricle involvement in systemic sclerosis. Radiology 271:373–380PubMedCrossRef
75.
Zurück zum Zitat Brooks J, Kramer CM, Salerno M (2013) Markedly increased volume of distribution of gadolinium in cardiac amyloidosis demonstrated by T1 mapping. J Magn Reson Imaging 38:1591–1595PubMedCrossRef Brooks J, Kramer CM, Salerno M (2013) Markedly increased volume of distribution of gadolinium in cardiac amyloidosis demonstrated by T1 mapping. J Magn Reson Imaging 38:1591–1595PubMedCrossRef
76.
Zurück zum Zitat Neilan TG, Coelho-Filho OR, Shah RV et al (2013) Myocardial extracellular volume fraction from T1 measurements in healthy volunteers and mice: relationship to aging and cardiac dimensions. JACC Cardiovasc Imaging 6:672–683PubMedPubMedCentralCrossRef Neilan TG, Coelho-Filho OR, Shah RV et al (2013) Myocardial extracellular volume fraction from T1 measurements in healthy volunteers and mice: relationship to aging and cardiac dimensions. JACC Cardiovasc Imaging 6:672–683PubMedPubMedCentralCrossRef
77.
Zurück zum Zitat Neilan TG, Coelho-Filho OR, Shah RV et al (2013) Myocardial extracellular volume by cardiac magnetic resonance imaging in patients treated with anthracycline-based chemotherapy. Am J Cardiol 111:717–722CrossRefPubMed Neilan TG, Coelho-Filho OR, Shah RV et al (2013) Myocardial extracellular volume by cardiac magnetic resonance imaging in patients treated with anthracycline-based chemotherapy. Am J Cardiol 111:717–722CrossRefPubMed
78.
Zurück zum Zitat Puntmann VO, D’Cruz D, Smith Z et al (2013) Native myocardial T1 mapping by cardiovascular magnetic resonance imaging in subclinical cardiomyopathy in patients with systemic lupus erythematosus. Circ Cardiovasc Imaging 6:295–301PubMedCrossRef Puntmann VO, D’Cruz D, Smith Z et al (2013) Native myocardial T1 mapping by cardiovascular magnetic resonance imaging in subclinical cardiomyopathy in patients with systemic lupus erythematosus. Circ Cardiovasc Imaging 6:295–301PubMedCrossRef
79.
Zurück zum Zitat Puntmann VO, Voigt T, Chen Z et al (2013) Native T1 mapping in differentiation of normal myocardium from diffuse disease in hypertrophic and dilated cardiomyopathy. JACC Cardiovasc Imaging 6:475–484PubMedCrossRef Puntmann VO, Voigt T, Chen Z et al (2013) Native T1 mapping in differentiation of normal myocardium from diffuse disease in hypertrophic and dilated cardiomyopathy. JACC Cardiovasc Imaging 6:475–484PubMedCrossRef
80.
Zurück zum Zitat Salerno M, Janardhanan R, Jiji RS et al (2013) Comparison of methods for determining the partition coefficient of gadolinium in the myocardium using T1 mapping. J Magn Reson Imaging 38:217–224PubMedCrossRef Salerno M, Janardhanan R, Jiji RS et al (2013) Comparison of methods for determining the partition coefficient of gadolinium in the myocardium using T1 mapping. J Magn Reson Imaging 38:217–224PubMedCrossRef
82.
Zurück zum Zitat Thompson RB, Chow K, Khan A et al (2013) T1 mapping with cardiovascular MRI is highly sensitive for Fabry disease independent of hypertrophy and sex. Circ Cardiovasc Imaging 6:637–645PubMedCrossRef Thompson RB, Chow K, Khan A et al (2013) T1 mapping with cardiovascular MRI is highly sensitive for Fabry disease independent of hypertrophy and sex. Circ Cardiovasc Imaging 6:637–645PubMedCrossRef
83.
Zurück zum Zitat Kawel N, Nacif M, Zavodni A et al (2012) T1 mapping of the myocardium: intra-individual assessment of post-contrast T1 time evolution and extracellular volume fraction at 3T for Gd-DTPA and Gd-BOPTA. J Cardiovasc Magn Reson 14:26PubMedPubMedCentralCrossRef Kawel N, Nacif M, Zavodni A et al (2012) T1 mapping of the myocardium: intra-individual assessment of post-contrast T1 time evolution and extracellular volume fraction at 3T for Gd-DTPA and Gd-BOPTA. J Cardiovasc Magn Reson 14:26PubMedPubMedCentralCrossRef
84.
Zurück zum Zitat Kellman P, Wilson JR, Xue H et al (2012) Extracellular volume fraction mapping in the myocardium, part 2: initial clinical experience. J Cardiovasc Magn Reson 14:64PubMedPubMedCentralCrossRef Kellman P, Wilson JR, Xue H et al (2012) Extracellular volume fraction mapping in the myocardium, part 2: initial clinical experience. J Cardiovasc Magn Reson 14:64PubMedPubMedCentralCrossRef
85.
Zurück zum Zitat Mongeon FP, Jerosch-Herold M, Coelho-Filho OR, Blankstein R, Falk RH, Kwong RY (2012) Quantification of extracellular matrix expansion by CMR in infiltrative heart disease. JACC Cardiovasc Imaging 5:897–907PubMed Mongeon FP, Jerosch-Herold M, Coelho-Filho OR, Blankstein R, Falk RH, Kwong RY (2012) Quantification of extracellular matrix expansion by CMR in infiltrative heart disease. JACC Cardiovasc Imaging 5:897–907PubMed
86.
Zurück zum Zitat Sado DM, Flett AS, Banypersad SM et al (2012) Cardiovascular magnetic resonance measurement of myocardial extracellular volume in health and disease. Heart 98:1436–1441PubMedCrossRef Sado DM, Flett AS, Banypersad SM et al (2012) Cardiovascular magnetic resonance measurement of myocardial extracellular volume in health and disease. Heart 98:1436–1441PubMedCrossRef
87.
Zurück zum Zitat Ugander M, Oki AJ, Hsu LY et al (2012) Extracellular volume imaging by magnetic resonance imaging provides insights into overt and sub-clinical myocardial pathology. Eur Heart J 33:1268–1278PubMedPubMedCentralCrossRef Ugander M, Oki AJ, Hsu LY et al (2012) Extracellular volume imaging by magnetic resonance imaging provides insights into overt and sub-clinical myocardial pathology. Eur Heart J 33:1268–1278PubMedPubMedCentralCrossRef
88.
Zurück zum Zitat Broberg CS, Chugh SS, Conklin C, Sahn DJ, Jerosch-Herold M (2010) Quantification of diffuse myocardial fibrosis and its association with myocardial dysfunction in congenital heart disease. Circ Cardiovasc Imaging 3:727–734 Broberg CS, Chugh SS, Conklin C, Sahn DJ, Jerosch-Herold M (2010) Quantification of diffuse myocardial fibrosis and its association with myocardial dysfunction in congenital heart disease. Circ Cardiovasc Imaging 3:727–734
89.
Zurück zum Zitat Jerosch-Herold M, Sheridan DC, Kushner JD et al (2008) Cardiac magnetic resonance imaging of myocardial contrast uptake and blood flow in patients affected with idiopathic or familial dilated cardiomyopathy. Am J Physiol Heart Circ Physiol 295:H1234–H1242PubMedPubMedCentralCrossRef Jerosch-Herold M, Sheridan DC, Kushner JD et al (2008) Cardiac magnetic resonance imaging of myocardial contrast uptake and blood flow in patients affected with idiopathic or familial dilated cardiomyopathy. Am J Physiol Heart Circ Physiol 295:H1234–H1242PubMedPubMedCentralCrossRef
90.
Zurück zum Zitat Arheden H, Saeed M, Higgins CB et al (1999) Measurement of the distribution volume of gadopentetate dimeglumine at echo-planar MR imaging to quantify myocardial infarction: comparison with 99mTc-DTPA autoradiography in rats. Radiology 211:698–7088PubMedCrossRef Arheden H, Saeed M, Higgins CB et al (1999) Measurement of the distribution volume of gadopentetate dimeglumine at echo-planar MR imaging to quantify myocardial infarction: comparison with 99mTc-DTPA autoradiography in rats. Radiology 211:698–7088PubMedCrossRef
91.
Zurück zum Zitat Roujol S, Weingärtner S, Foppa M et al (2014) Accuracy, precision, and reproducibility of four T1 mapping sequences: a head-to-head comparison of MOLLI, ShMOLLI, SASHA, and SAPPHIRE. Radiology 272:683–689PubMedCrossRef Roujol S, Weingärtner S, Foppa M et al (2014) Accuracy, precision, and reproducibility of four T1 mapping sequences: a head-to-head comparison of MOLLI, ShMOLLI, SASHA, and SAPPHIRE. Radiology 272:683–689PubMedCrossRef
92.
Zurück zum Zitat Bauner KU, Biffar A, Theisen D et al (2012) Extracellular volume fractions in chronic myocardial infarction. Invest Radiol 47:538–545PubMedCrossRef Bauner KU, Biffar A, Theisen D et al (2012) Extracellular volume fractions in chronic myocardial infarction. Invest Radiol 47:538–545PubMedCrossRef
94.
Zurück zum Zitat Sardanelli F, Alì M, Hunink MG, Houssami N, Sconfienza LM, Di Leo G (2018) To share or not to share? Expected pros and cons of data sharing in radiological research. Eur Radiol 28:2328–2335PubMedCrossRef Sardanelli F, Alì M, Hunink MG, Houssami N, Sconfienza LM, Di Leo G (2018) To share or not to share? Expected pros and cons of data sharing in radiological research. Eur Radiol 28:2328–2335PubMedCrossRef
96.
Zurück zum Zitat Karamitsos TD, Piechnik SK, Banypersad SM et al (2013) Noncontrast T1 mapping for the diagnosis of cardiac amyloidosis. JACC Cardiovasc Imaging 6:488–497PubMedCrossRef Karamitsos TD, Piechnik SK, Banypersad SM et al (2013) Noncontrast T1 mapping for the diagnosis of cardiac amyloidosis. JACC Cardiovasc Imaging 6:488–497PubMedCrossRef
97.
Zurück zum Zitat Treibel TA, Fontana M, Maestrini V et al (2016) Automatic measurement of the myocardial interstitium: synthetic extracellular volume quantification without hematocrit sampling. JACC Cardiovasc Imaging 9:54–63PubMedCrossRef Treibel TA, Fontana M, Maestrini V et al (2016) Automatic measurement of the myocardial interstitium: synthetic extracellular volume quantification without hematocrit sampling. JACC Cardiovasc Imaging 9:54–63PubMedCrossRef
98.
Zurück zum Zitat Robison S, Karur GR, Wald RM, Thavendiranathan P, Crean AM, Hanneman K (2018) Noninvasive hematocrit assessment for cardiovascular magnetic resonance extracellular volume quantification using a point-of-care device and synthetic derivation. J Cardiovasc Magn Reson 20:19PubMedPubMedCentralCrossRef Robison S, Karur GR, Wald RM, Thavendiranathan P, Crean AM, Hanneman K (2018) Noninvasive hematocrit assessment for cardiovascular magnetic resonance extracellular volume quantification using a point-of-care device and synthetic derivation. J Cardiovasc Magn Reson 20:19PubMedPubMedCentralCrossRef
99.
Zurück zum Zitat Messroghli DR, Moon JC, Ferreira VM et al (2017) Clinical recommendations for cardiovascular magnetic resonance mapping of T1, T2, T2* and extracellular volume: a consensus statement by the Society for Cardiovascular Magnetic Resonance (SCMR) endorsed by the European Association for Cardiovascular Imaging (EACVI). J Cardiovasc Magn Reson 19:75PubMedPubMedCentralCrossRef Messroghli DR, Moon JC, Ferreira VM et al (2017) Clinical recommendations for cardiovascular magnetic resonance mapping of T1, T2, T2* and extracellular volume: a consensus statement by the Society for Cardiovascular Magnetic Resonance (SCMR) endorsed by the European Association for Cardiovascular Imaging (EACVI). J Cardiovasc Magn Reson 19:75PubMedPubMedCentralCrossRef
Metadaten
Titel
Point estimate and reference normality interval of MRI-derived myocardial extracellular volume in healthy subjects: a systematic review and meta-analysis
verfasst von
Francesco Sardanelli
Simone Schiaffino
Moreno Zanardo
Francesco Secchi
Paola Maria Cannaò
Federico Ambrogi
Giovanni Di Leo
Publikationsdatum
02.05.2019
Verlag
Springer Berlin Heidelberg
Erschienen in
European Radiology / Ausgabe 12/2019
Print ISSN: 0938-7994
Elektronische ISSN: 1432-1084
DOI
https://doi.org/10.1007/s00330-019-06185-w

Weitere Artikel der Ausgabe 12/2019

European Radiology 12/2019 Zur Ausgabe

„Übersichtlicher Wegweiser“: Lauterbachs umstrittener Klinik-Atlas ist online

17.05.2024 Klinik aktuell Nachrichten

Sie sei „ethisch geboten“, meint Gesundheitsminister Karl Lauterbach: mehr Transparenz über die Qualität von Klinikbehandlungen. Um sie abzubilden, lässt er gegen den Widerstand vieler Länder einen virtuellen Klinik-Atlas freischalten.

Klinikreform soll zehntausende Menschenleben retten

15.05.2024 Klinik aktuell Nachrichten

Gesundheitsminister Lauterbach hat die vom Bundeskabinett beschlossene Klinikreform verteidigt. Kritik an den Plänen kommt vom Marburger Bund. Und in den Ländern wird über den Gang zum Vermittlungsausschuss spekuliert.

Darf man die Behandlung eines Neonazis ablehnen?

08.05.2024 Gesellschaft Nachrichten

In einer Leseranfrage in der Zeitschrift Journal of the American Academy of Dermatology möchte ein anonymer Dermatologe bzw. eine anonyme Dermatologin wissen, ob er oder sie einen Patienten behandeln muss, der eine rassistische Tätowierung trägt.

Ein Drittel der jungen Ärztinnen und Ärzte erwägt abzuwandern

07.05.2024 Klinik aktuell Nachrichten

Extreme Arbeitsverdichtung und kaum Supervision: Dr. Andrea Martini, Sprecherin des Bündnisses Junge Ärztinnen und Ärzte (BJÄ) über den Frust des ärztlichen Nachwuchses und die Vorteile des Rucksack-Modells.

Update Radiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.